EC
Euclidean Capital Portfolio holdings
AUM
$238M
1-Year Est. Return
21.65%
1 Year Est. Return
+21.65%
AUM
$238M
AUM Growth
-$67.7M
(-22%)
Holding
11
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vanguard FTSE All-World ex-US ETF
VEU
$52.6B
| $184M | 77.31% |
2,578,184
+435,500
|
|
||
2
iShares MSCI India ETF
INDA
$9.46B
| $19.2M | 8.08% |
369,600
-2,055,544
|
|
||
3
Oric Pharmaceuticals
ORIC
$1.12B
| $11.9M | 4.99% |
989,410
|
|
||
4
Foghorn Therapeutics
FHTX
$261M
| $7.7M | 3.23% |
1,573,761
|
|
||
5
Alector
ALEC
$132M
| $3.87M | 1.63% |
1,307,858
|
|
||
6
PMV Pharmaceuticals
PMVP
$68.1M
| $3.68M | 1.55% |
2,627,643
|
|
||
7
SPDR S&P 500 ETF Trust
SPY
$701B
| $2.73M | 1.15% |
4,104
|
|
||
8
RAPT Therapeutics
RAPT
$962M
| $2.12M | 0.89% |
82,234
|
|
||
9
Tenaya Therapeutics
TNYA
$235M
| $1.65M | 0.69% |
1,015,705
|
|
||
10
Surrozen
SRZN
$156M
| $1.13M | 0.47% |
87,696
|
|
||
|
11
Surrozen Inc Warrant
SRZNW
$47.8K
| $3.42K | ﹤0.01% |
170,833
|
|